litlas
Log inCreate account

Timo Vesikari

Active 1968–2023

106
Papers
21,364
Citations
78
h-index
106
i10-index

Citations

Citations per year for Timo Vesikari1969: 3 citations1972: 1 citations1973: 1 citations1974: 1 citations1977: 1 citations1978: 2 citations1979: 1 citations1980: 3 citations1981: 1 citations1983: 6 citations1984: 10 citations1985: 17 citations1986: 35 citations1987: 13 citations1988: 20 citations1989: 23 citations1990: 24 citations1991: 14 citations1992: 15 citations1993: 11 citations1994: 10 citations1995: 17 citations1996: 23 citations1997: 34 citations1998: 37 citations1999: 51 citations2000: 80 citations2001: 90 citations2002: 114 citations2003: 67 citations2004: 73 citations2005: 92 citations2006: 137 citations2007: 166 citations2008: 157 citations2009: 201 citations2010: 234 citations2011: 145 citations2012: 182 citations2013: 150 citations2014: 181 citations2015: 110 citations2016: 135 citations2017: 140 citations2018: 154 citations2019: 543 citations2020: 457 citations2021: 498 citations2022: 306 citations2023: 197 citations2024: 366 citations2025: 179 citations1970–1971: no citations, so these years are not shown1975–1976: no citations, so these years are not shown1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,525 citing papers, 25% of this breakdownUnited Kingdom: 421 citing papers, 6.9% of this breakdownItaly: 260 citing papers, 4.3% of this breakdownCanada: 236 citing papers, 3.9% of this breakdownBelgium: 227 citing papers, 3.7% of this breakdownFinland: 221 citing papers, 3.6% of this breakdownAustralia: 207 citing papers, 3.4% of this breakdownChina: 203 citing papers, 3.3% of this breakdownGermany: 192 citing papers, 3.2% of this breakdownFrance: 180 citing papers, 3% of this breakdownSpain: 149 citing papers, 2.5% of this breakdownIndia: 149 citing papers, 2.4% of this breakdown
0%25%Other 34.8%

Institutions

Fields

  • Medicine71%
  • Biochemistry, Genetics and Molecular Biology9%
  • Agricultural and Biological Sciences8.1%
  • Immunology and Microbiology7%
  • Nursing1.4%
  • Social Sciences1.1%
  • Other2.4%

Topics

  • Viral gastroenteritis research and epidemiology12.3%
  • Respiratory viral infections research6.1%
  • Influenza Virus Research Studies4.4%
  • Herpesvirus Infections and Treatments4%
  • Probiotics and Fermented Foods4%
  • Viral Infections and Immunology Research3.9%
  • Other65.3%

Coauthors

All papers

Open in search
  1. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

    Authors: Himal Lal, Anthony L. Cunningham, Olivier Godeaux, Roman Chlíbek, Javier Díez‐Domingo, Shinn‐Jang Hwang, Myron J. Levin, Janet E. McElhaney, Airi Põder, Joan Puig‐Barberà, Timo Vesikari, Daisuke Watanabe, Lily Yin Weckx, Toufik Zahaf, Thomas C. Heineman - New England Journal of Medicine 2015 cited by 1,417

  2. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

    Authors: Anthony L. Cunningham, Himal Lal, Martina Kovac, Roman Chlíbek, Shinn‐Jang Hwang, Javier Díez‐Domingo, Olivier Godeaux, Myron J. Levin, Janet E. McElhaney, Joan Puig‐Barberà, Carline Vanden Abeele, Timo Vesikari, Daisuke Watanabe, Toufik Zahaf, Anitta Ahonen, Eugene Athan, José Fernando Barba‐Gómez, Laura Cámpora, Ferdinandus de Looze, H. Jackson Downey, Wayne Ghesquière, Iris Gorfinkel, Tiina Korhonen, Edward Leung, Shelly McNeil, Lidia Oostvogels, Lars Rombo, Jan Smetana, Lily Yin Weckx, W W Yeo, Thomas C. Heineman - New England Journal of Medicine 2016 cited by 1,043

  3. Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

    Authors: Steven Black, Uwe Nicolay, Timo Vesikari, Markus Knuf, Giuseppe Del Giudice, Giovanni Della Cioppa, Theodore F. Tsai, Ralf Clemens, Rino Rappuoli - The Pediatric Infectious Disease Journal 2011 cited by 337

  4. Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

    Authors: Anthony L. Cunningham, Thomas C. Heineman, Himal Lal, Olivier Godeaux, Roman Chlíbek, Shinn‐Jang Hwang, Janet E. McElhaney, Timo Vesikari, Charles P. Andrews, Won Suk Choi, Meral Esen, Hideyuki Ikematsu, Martina Kovac Choma, Karlis Pauksens, Stéphanie Ravault, Bruno Salaun, Tino F. Schwarz, Jan Smetana, Carline Vanden Abeele, Peter van Steen, Ilse Vastiau, Lily Yin Weckx, Myron J. Levin, ZOE-50/70 Study Group - The Journal of Infectious Diseases 2018 cited by 200

  5. Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials

    Authors: Brian J. Ward, А. И. Макарков, Annie Séguin, Stéphane Pillet, Sonia Trépanier, Jiwanjeet K. Dhaliwall, Michael Libman, Timo Vesikari, Nathalie Landry - The Lancet 2020 cited by 192

  6. Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years

    Authors: Ken Schmader, Myron J. Levin, J. W. Gnann, Shelly McNeil, Timo Vesikari, Robert F. Betts, S. Keay, Jon E. Stek, Nickoya D. Bundick, Shu-Jem Su, Yanli Zhao, Xiaoming Li, I. S. F. Chan, Paula W. Annunziato, Janie Parrino - Clinical Infectious Diseases 2012 cited by 431

  7. Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

    Authors: Guillermo M. Ruiz‐Palacios, Irene Pérez‐Schael, F. Raúl Velázquez, Héctor Abate, Thomas Breuer, Sue Ann Costa Clemens, Brigitte Cheuvart, Félix Espinoza, Paul Gillard, Bruce L. Innis, Yolanda Cervantes, Alexandre C. Linhares, Pío López, Mercedes Macías-Parra, Eduardo Ortega‐Barría, Vesta Richardson, Doris Maribel Rivera-Medina, Luis Rivera, Belén Salinas, Noris Pavía-Ruz, Jorge Salmerón, Ricardo Rüttimann, Juan Carlos Tinoco, Pilar Rubio, Ernesto Nuñez, M. Lourdes Guerrero, Juan Pablo Yarzábal, Silvia Damaso, Nadia Tornieporth, Xavier Sáez‐Llorens, Rodrigo Vergara, Timo Vesikari, Alain Bouckenooghe, Ralf Clemens, Béatrice De Vos, Miguel O’Ryan - New England Journal of Medicine 2006 cited by 1,815

  8. Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine

    Authors: Timo Vesikari, David O. Matson, Penelope H. Dennehy, Pierre Van Damme, Mathuram Santosham, Zoe Rodriguez, Michael J. Dallas, Joseph F. Heyse, Michelle G. Goveia, Steven Black, Henry R. Shinefield, C D C Christie, Samuli Ylitalo, Robbin Itzler, Michele L. Coia, Matthew Onorato, Ben Adeyi, Gary S. Marshall, Leif Gothefors, Dirk Campens, Aino Karvonen, James Watt, Katherine L. O’Brien, Mark J. DiNubile, H. F. Clark, John W. Boslego, Paul A. Offit, Penny M. Heaton - New England Journal of Medicine 2006 cited by 1,882

  9. Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children

    Authors: Robert B. Belshe, Kathryn M. Edwards, Timo Vesikari, Steven V. Black, Robert Walker, Micki Hultquist, George Kemble, Edward M. Connor - New England Journal of Medicine 2007 cited by 811

  10. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

    Authors: Timo Vesikari, Aino Karvonen, Roman Prymula, Volker Schuster, JC Tejedor, Robert Cohen, François Meurice, H.H. Han, Silvia Damaso, Alain Bouckenooghe - The Lancet 2007 cited by 641

  11. Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine

    Authors: Timo Vesikari, Adam Finn, Pierre Van Damme, Isabel Leroux‐Roels, Geert Leroux‐Roels, Nathan Segall, Azhar Toma, Gerald Vallieres, Ronnie Aronson, Dennis Reich, Samir Arora, Peter Ruane, Clancy Cone, Michael P. Manns, Catherine Cosgrove, Saul N. Faust, Maheshi Ramasamy, Nathalie Machluf, Johanna N. Spaans, Bebi Yassin-Rajkumar, David E. Anderson, Vlad Popovic, Francisco Díaz‐Mitoma, CONSTANT Study Group, Bruce Rankin, Mary Beth Manning, Carl Griffin, Amina Z. Haggag, Mark E Kutner, M. Turner, Barbara Rizzardi, Hayes Williams, Michael Levin, Hamilton Sah, Naveen Garg, Aino Forstén, Ilkka Seppä, Maija Rössi, Anitta Ahonen, Olli Henriksson, Benita Ukkonen, Satu Kokko, Outi Laajalahti, Pauliina Paavola - JAMA Network Open 2021 cited by 61

  12. One-step quantitative RT-PCR for the detection of rotavirus in acute gastroenteritis

    Authors: Shang‐Qin Zeng, Anne Halkosalo, Marjo Salminen, E. D. Szakal, Leena Puustinen, Timo Vesikari - Journal of Virological Methods 2008 cited by 222

  13. Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

    Authors: Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois, Mohamed El Idrissi, Lidia Oostvogels, Ferdinandus J. de Looze, Javier Díez‐Domingo, Thomas C. Heineman, Himal Lal, Janet E. McElhaney, Shelly McNeil, W W Yeo, Fernanda Tavares Da Silva, Anitta Ahonen, Thiago Junqueira Avelino‐Silva, José Fernando Barba‐Gómez, Johan Berglund, Carlos Brotons Cuixart, Covadonga Caso, Roman Chlíbek, Won Suk Choi, Anthony L. Cunningham, Maria Guiseppina Desole, Peter Eizenberg, Meral Esen, Emmanuelle Espié, P Gervais, Wayne Ghesquière, Olivier Godeaux, Iris Gorfinkel, David S.C. Hui, Shinn‐Jang Hwang, Tiina Korhonen, Martina Kovac, Edouard Ledent, Edward Leung, Myron J. Levin, Silvia Narejos Pérez, José Luiz Costa Neto, Karlis Pauksens, Airi Põder, María Luisa Rodríguez de la Pinta, Lars Rombo, Tino F. Schwarz, Jan Smetana, Tommaso Staniscia, Juan Carlos Tinoco, Azhar Toma, Ilse Vastiau, Timo Vesikari, Antonio Volpi, Daisuke Watanabe, Lily Yin Weckx, Toufik Zahaf - Vaccine 2019 cited by 65

  14. Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial

    Authors: Timo Vesikari, Joanne M. Langley, Nathan Segall, Brian J. Ward, Curtis Cooper, Guillaume Poliquin, Bruce R. Smith, Soren Gantt, Janet E. McElhaney, Marc Dionne, Pierre Van Damme, Isabel Leroux‐Roels, Geert Leroux‐Roels, Nathalie Machluf, Johanna N. Spaans, Bebi Yassin-Rajkumar, David E. Anderson, Vlad Popovic, Francisco Díaz‐Mitoma, Timo Vesikari, Joanne M. Langley, Soren Gantt, Marc Dionne, Janet E. McElhaney, Bruce Rankin, Carl Griffin, Mark Turner, Judith L. Kirstein, Barbara Rizzardi, Hayes Williams, Anitta Ahonen, Olli Henriksson, Benita Ukkonen, Marita Paassilta, Nathan Segall, Brian J. Ward, Curtis Cooper, Guillaume Poliquin, Bruce R. Smith, Pierre Van Damme, Isabel Leroux‐Roels, Geert Leroux‐Roels, Nathalie Machluf, Johanna N. Spaans, Bebi Yassin-Rajkumar, David E. Anderson, Vlad Popovic, Francisco Díaz‐Mitoma - The Lancet Infectious Diseases 2021 cited by 72

  15. PreHevbrio: the first approved 3-antigen hepatitis B vaccine

    Authors: Timo Vesikari, Joanne M. Langley, Vlad Popovic, Francisco Díaz‐Mitoma - Expert Review of Vaccines 2023 cited by 17

  16. Rotavirus Disease in Finnish Children: Use of Numerical Scores for Clinical Severity of Diarrhoeal Episodes

    Authors: Tarja Ruuska, Timo Vesikari - Scandinavian Journal of Infectious Diseases 1990 cited by 730

  17. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

    Authors: David Greenberg, Patricia Hoover, Timo Vesikari, Christopher B. Peltier, David Hurley, Richard McFetridge, Michael J. Dallas, Jonathan Hartzel, Rocio D. Marchese, Beth-Ann Coller, Jon E. Stek, Chitrananda Abeygunawardana, Michael A. Winters, John E. MacNair, Narahari S. Pujar, Luwy Musey - Vaccine 2018 cited by 107

  18. Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in Mice

    Authors: Kirsi Tamminen, Suvi Lappalainen, Leena Huhti, Timo Vesikari, Vesna Blazevic - PLoS ONE 2013 cited by 103

  19. Primary Versus Secondary Failure After Varicella Vaccination

    Authors: Paolo Bonanni, Anne A. Gershon, Michael D. Gershon, Andrea Kulcsár, Vassiliki Papaevangelou, Bernard Rentier, Catherine Sadzot‐Delvaux, Vytautas Usonis, Timo Vesikari, Catherine Weil-Olivier, Peter de Winter, Peter Wutzler - The Pediatric Infectious Disease Journal 2013 cited by 85

  20. Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings

    Authors: Joanne M. Langley, Véronique Bianco, Joseph B. Domachowske, Shabir A. Madhi, Sonia Stoszek, Khalequ Zaman, Agustin Bueso, Ana Ceballos, Luis Cousin, Ulises D’Andrea, Ilse Dieussaert, Janet A. Englund, Sanjay Gandhi, Olivier Gruselle, Gerco Haars, Lisa Jose, Nicola P. Klein, Amanda Leach, Koen Maleux, Thi Lien Anh Nguyen, Thanyawee Puthanakit, Peter Silas, Auchara Tangsathapornpong, Jamaree Teeratakulpisarn, Timo Vesikari, Rachel Cohen - The Journal of Infectious Diseases 2022 cited by 38

  21. Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children

    Authors: Timo Vesikari, Markus Knuf, Peter Wutzler, Aino Karvonen, Dorothee Kieninger‐Baum, Heinz‐Josef Schmitt, Frank Baehner, Astrid Borkowski, Theodore F. Tsai, Ralf Clemens - New England Journal of Medicine 2011 cited by 317

  22. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis

    Authors: Vesna Blazevic, Suvi Lappalainen, Kirsi Nurminen, Leena Huhti, Timo Vesikari - Vaccine 2011 cited by 143

  23. Rotavirus Vaccination Does Not Increase Type 1 Diabetes and May Decrease Celiac Disease in Children and Adolescents

    Authors: Maria Hemming‐Harlo, Marja‐Leena Lähdeaho, Markku Mäki, Timo Vesikari - The Pediatric Infectious Disease Journal 2019 cited by 75

  24. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

    Authors: Timo Vesikari, Susanna Esposito, Roman Prymula, Ellen Ypma, Igor Kohl, Daniela Toneatto, Peter Dull, Alan Kimura - The Lancet 2013 cited by 274